During the past decade, Prosper-Hospital, Medizinische Klinik I conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 6 clinical trials were completed, i.e. on average, 150% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 3 clinical trials were completed. i.e. 150% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Prosper-Hospital, Medizinische Klinik I" #1 sponsor was "Hoffmann-La Roche" with 5 trials, followed by "ResMed" with 3 trials sponsored, "BioNTech SE" with 2 trials sponsored, "German High-Grade Non-Hodgkin's Lymphoma Study Group" with 2 trials sponsored and "Advancell - Advanced In Vitro Cell Technologies, S.A." with 2 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Prosper-Hospital, Medizinische Klinik I" #1 collaborator was "CRI-The Clinical Research Institute GmbH" with 1 trials as a collaborator, "Charite University, Berlin, Germany" with 1 trials as a collaborator, "ClinAssess GmbH" with 1 trials as a collaborator, "Cromsource" with 1 trials as a collaborator and "Genentech, Inc." with 1 trials as a collaborator. Other collaborators include 2 different institutions and companies that were collaborators in the rest 12 trials.

According to Clinical.Site data, the most researched conditions in "Prosper-Hospital, Medizinische Klinik I" are "Colorectal Cancer Stage II" (2 trials), "Colorectal Cancer Stage III" (2 trials), "Heart Failure" (2 trials), "Lymphoma" (2 trials) and "Non-Hodgkin's Lymphoma" (2 trials). Many other conditions were trialed in "Prosper-Hospital, Medizinische Klinik I" in a lesser frequency.

Most popular intervention types in "Prosper-Hospital, Medizinische Klinik I" are "Drug" (13 trials), "Biological" (3 trials), "Radiation" (3 trials), "Device" (2 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Cyclophosphamide" (3 trials), "cyclophosphamide" (3 trials), "Bevacizumab" (2 trials), "Doxorubicin" (2 trials) and "Placebo" (2 trials). Other intervention names were less common.

The vast majority of trials in "Prosper-Hospital, Medizinische Klinik I" are 18 trials for "All" genders.

Currently, there are NaN active trials in "Prosper-Hospital, Medizinische Klinik I". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 11 completed trials in Prosper-Hospital, Medizinische Klinik I, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Prosper-Hospital, Medizinische Klinik I, 2 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".